AUPH

Aurinia Pharmaceuticals (AUPH)

About Aurinia Pharmaceuticals (AUPH)

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Details

Daily high

$15.98

Daily low

$15.57

Price at open

$15.65

52 Week High

$16.48

52 Week Low

$6.55

Market cap

2.1B

Dividend yield

0.00%

Volume

943,732

Avg. volume

1.6M

P/E ratio

27.96

Aurinia Pharmaceuticals News